Hunting for predictive computational drug-discovery models

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 3, 2008, Pages 291-293

  Snow, Christopher D ^a  

^a Department of Chemical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ANALYTICAL ERROR; BINDING AFFINITY; COMPUTER AIDED DESIGN; COMPUTER PREDICTION; CONFERENCE PAPER; CRYSTALLOGRAPHY; DRUG BINDING; DRUG DESIGN; DRUG INDUSTRY; DRUG RESEARCH; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; MATHEMATICAL COMPUTING; MOLECULAR MODEL; PROCESS OPTIMIZATION; PROFESSIONAL PRACTICE; PROTEIN ANALYSIS; PROTEIN DATA BANK; BIOLOGY; METHODOLOGY; RESEARCH; REVIEW;

COMPUTATIONAL BIOLOGY; COMPUTER-AIDED DESIGN; DRUG DESIGN; DRUG INDUSTRY; RESEARCH;

EID: 48449098167     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.3.291     Document Type: Conference Paper

References (18)

1. Kleywegt GJ, Harris MR, Zou JY, Taylor TC, Wahlby A, Jones TA. The Uppsala Electron-Density Server. Acta Crystallogr. D Biol. Crystallogr. 60(12 Pt 1), 2240-2249 (2004).
2. Levin EJ, Kondrashov DA, Wesenberg GE, Phillips GN Jr. Ensemble refinement of protein crystal structures: validation and application. Structure 15(9), 1040-1052 (2007).
3. Poon BK, Chen X, Lu M et al. Normal mode refinement of anisotropic thermal parameters for a supramolecular complex at 3.42aA crystallographic resolution. Proc. Natl Acad. Sci. USA 104(19), 7869-7874 (2007).
4. Case DA, Cheatham TE 3rd, Darden T et al. The Amber biomolecular simulation programs. J. Comput. Chem. 26(16), 1668-1688 (2005).
5. Hawkins PC, Warren GL, Skillman AG, Nicholls A. How to do an evaluation: pitfalls and traps. J. Comput. Aided Mol. Des. 22(3-4), 179-190 (2008).
6. Tirado-Rives J, Jorgensen WL. Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. J. Med. Chem. 49(20), 5880-5884 (2006).
7. Jorgensen WL, Ruiz-Caro J, Tirado-Rives J, Basavapathruni A, Anderson KS, Hamilton AD. Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 16(3), 663-667 (2006).
8. Wang J, Deng Y, Roux B. Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials. Biophys. J. 91 (8), 2798-2814 (2006).
9. Steuber H, Heine A, Klebe G. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution. J. Mol. Biol. 368(3), 618-638 (2007).
10. Gerlach C, Smolinski M, Steuber H et al. Thermodynamic inhibition profile of a cyclopentyl and a cyclohexyl derivative towards thrombin: the same but for different reasons. Angew. Chem. Int. Ed. Engl. 46(44), 8511-8514 (2007).
11. Feng BY, Simeonov A, Jadhav A et al. A high-throughput screen for aggregation-based inhibition in a large compound library. J. Med. Chem. 50(10), 2385-2390 (2007).
12. Babaoglu K, Simeonov A, Irwin JJ et al. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase. J. Med. Chem. 51(8), 2502-2511(2008).
13. Kuntz ID, Chen K, Sharp KA, Kollman PA. The maximal affinity of ligands. Proc. Natl Acad. Sci. USA 96(18), 9997-10002 (1999).
14. Reynolds CH, Tounge BA, Bembenek SD. Ligand binding efficiency: trends, physical basis, and implications. J. Med. Chem. 51(8), 2432-2438 (2008).
15. Hajduk PJ. Fragment-based drug design: how big is too big? J. Med. Chem. 49(24), 6972-6976(2006).
16. Hajduk PJ. Puzzling through fragment-based drug design. Nat. Chem. Biol. 2(12), 658-659 (2006).
17. Babaoglu K, Shoichet BK. Deconstructing fragment-based inhibitor discovery. Nat. Chem. Biol. 2(12), 720-723 (2006).
18. Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov. 6(3), 211-219 (2007).